相关实验视频

Updated: Sep 16, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

通过结构-活性关系分析,释放强大的抗结核天然产品

Delfly Booby Abdjul^1,2, Fitri Budiyanto³, Joko Tri Wibowo³

¹Research Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Jalan Raya Jakarta Bogor KM.46, Cibinong, Bogor, West Java, 16911, Indonesia. booby_abdjul@yahoo.com.

Natural products and bioprospecting

|July 7, 2025

概括

自然产品为开发针对耐药菌株的新结核病 (TB) 药物提供了有希望的途径. 本综述分析了强效的结核病天然产品,它们的结构-活性关系,以及用于有效药物发现的细胞毒性.

科学领域:

药用化学医学化学
自然产品化学化学
计算化学的计算化学

背景情况:

结核病 (TB) 由于耐药性和长期治疗而构成重大全球卫生挑战.
迫切需要新型抗结核病药物,具有新的作用机制.
自然产品是药物发现的各种生物活性化合物的丰富来源.

研究的目的:

审查有效的抗结核天然产品 (MIC < 5μg/mL).
检查这些化合物的结构-活性关系 (SAR).
评估抗结核病功效与细胞毒性之间的相关性.

主要方法:

对具有抗结核病活性的天然产品的文献综述.
使用随机森林机器学习分析结构-活动关系 (SAR).
使用AutoDock Vina进行分子对接研究,以预测目标相互作用.
XGBoost机器学习模型,以提高预测准确度.

主要成果:

鉴定出具有显著抗结核病活性的强效天然产品.
通过SAR分析阐明了通过SAR分析对抗结核病疗效有助于提高的关键结构特征.
评估了化合物功效和宿主细胞细胞毒性之间的关系.

结论:

自然产品是新型抗结核病药物发现的宝贵资源.
了解SAR和细胞毒性对于识别有前途的药物支架至关重要.
计算方法有助于预测和优化抗结核病化合物的疗效.

关键词:

抗结核病支架抗结核病支架自然产品自然产品结构活动关系结构活动关系结核病是一种疾病.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...